GT Biopharma, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies (NCT03214666) | GT Biopharma, Inc. | 2020-01-01 |
Track GT Biopharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.